1. Home
  2. Analysis
  3. Voltaren
  4. Tyvaso-dpi

Voltaren and Tyvaso dpi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Voltaren (diclofenac sodium) and Tyvaso dpi (treprostinil). Common drug interactions include cough among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Voltaren and Tyvaso dpi. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.

What is Tyvaso dpi?

Tyvaso dpi has active ingredients of treprostinil. eHealthMe is studying from 3,551 Tyvaso dpi users. Check the latest studies of Tyvaso dpi.

On Aug, 11, 2026

22 people who take Voltaren and Tyvaso dpi together, and have interactions are studied.

Voltaren and Tyvaso dpi drug interactions.

What are the common drug interactions of Voltaren and Tyvaso Dpi, by gender? *:

female:

  1. Cough
  2. Throat irritation
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Blood pressure increased
  5. Chest discomfort
  6. Productive cough
  7. Dyspnoea (difficult or laboured respiration)
  8. Epistaxis (bleed from the nose)
  9. Hypotension (abnormally low blood pressure)
  10. Diarrhoea

male:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. Heart rate irregular
  4. Loss of consciousness
  5. Presyncope
  6. Chest pain
  7. Fatigue (feeling of tiredness)
  8. Vertigo
  9. Heart rate decreased
  10. Eye injury

What are the common drug interactions of Voltaren and Tyvaso Dpi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Drug ineffective

50-59:

  1. Cough
  2. Headache (pain in head)
  3. Oxygen saturation decreased
  4. Throat irritation

60+:

  1. Asthenia (weakness)
  2. Cardiac failure congestive
  3. Blood pressure increased
  4. Pericardial effusion (fluid around the heart)
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Dizziness
  8. Drug ineffective
  9. Dyspnoea (difficult or laboured respiration)
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 22 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Voltaren and Tyvaso dpi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Voltaren and Tyvaso dpi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Voltaren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tyvaso dpi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Voltaren and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tyvaso dpi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac sodium and treprostinil (the active ingredients of Voltaren and Tyvaso dpi, respectively), and Voltaren and Tyvaso dpi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.